About EndoStim
EndoStim is a company based in St. Louis (United States) founded in 2009 by Virender Sharma. EndoStim has raised $75.78 million across 10 funding rounds from investors including Gimv, Wellington Partners Venture Capital and Sante Ventures. EndoStim offers products and services including EndoStim System. EndoStim operates in a competitive market with competitors including EndoChoice, EndoGastric Solutions, CoapTech, SafeStitch and Endo Tools Therapeutics, among others.
- Headquarter St. Louis, United States
- Founders Virender Sharma
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Endostim, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$75.78 M (USD)
in 10 rounds
-
Latest Funding Round
$2.81 M (USD), Series D
Dec 31, 2018
-
Investors
Gimv
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of EndoStim
EndoStim offers a comprehensive portfolio of products and services, including EndoStim System.
Neurostimulation system for treating GERD via electrical signals to the LES.
People of EndoStim
Unlock access to complete
Leadership Team
3 people
Finance and Accounting
1 people
Legal and Compliance
1 people
CTO Team
1 people
Unlock access to complete
Funding Insights of EndoStim
EndoStim has successfully raised a total of $75.78M across 10 strategic funding rounds. The most recent funding activity was a Series D round of $2.81 million completed in December 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in EndoStim
EndoStim has secured backing from 8 investors, including venture fund investors. Prominent investors backing the company include Gimv, Wellington Partners Venture Capital and Sante Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm
|
Locked | Locked | Locked | |
|
Investments are made in early-stage healthcare startups.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for EndoStim
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by EndoStim
Investment portfolio details for EndoStim
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - EndoStim
Detailed financials for EndoStim
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Endostim Comparisons
Peer comparison for EndoStim
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of EndoStim
EndoStim operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EndoChoice, EndoGastric Solutions, CoapTech, SafeStitch and Endo Tools Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Devices, systems, and services are provided for GI specialists.
|
|
| Locked | Locked | Locked |
Incisionless transoral procedures for upper GI diseases are developed.
|
|
| Locked | Locked | Locked |
Minimally invasive gastrostomy feeding tube placement method is developed.
|
|
| Locked | Locked | Locked |
Medical devices for gastrointestinal and bariatric surgery are developed.
|
|
| Locked | Locked | Locked |
Endoscopic catheters for precision in gastroenterology are developed.
|
Detailed competitors of EndoStim
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Endostim
Complete news archive for EndoStim
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EndoStim
EndoStim was founded in 2009.
EndoStim is headquartered in St. Louis, United States. It is registered at St. Louis, Missouri, United States.
EndoStim is a funded company, having raised a total of $75.78M across 10 funding rounds to date.
EndoStim is a medical device company that has developed a device-based therapy for Gastro-esophageal Reflux Disease (GERD) through electrical stimulation. The EndoStim therapy consists of a bipolar lead which delivers low energy electrical pulses to the patients weak or dysfunctional lower esophageal sphincter. Company withdrew 35M IPO plans in Sep 2015 citing poor market conditions.
EndoStim's top competitors include CoapTech, Endo Tools Therapeutics and EndoChoice.
EndoStim offers EndoStim System.
EndoStim has 8 investors. Key investors include Gimv, Wellington Partners Venture Capital, Sante Ventures, Endeavour Vision, and Prettybrook Partners.